Filtered By:
Specialty: Neurology
Condition: Diabetes

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 1939 results found since Jan 2013.

MELAS Syndrome: How Stroke-like are the Stroke episodes? (P1.255)
Conclusions:Patients with MELAS syndrome may present with recurrent strokes in the arterial territory rather than SLEs. Clinicians should entertain the possibility of a mitochondrial disease in young patients with cryptogenic stroke and pursue appropriate diagnostic evaluations and treatment.Disclosure: Dr. Liaw has nothing to disclose. Dr. Lewis has nothing to disclose. Dr. Saini has nothing to disclose. Dr. Gultekin has nothing to disclose. Dr. Koch has nothing to disclose. Dr. Asdaghi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Liaw, N., Lewis, R., Saini, V., Gultekin, S. H., Koch, S., Asdaghi, N. Tags: Genetic Stroke Syndromes, Biomarkers, and Translational/Basic Research Source Type: research

Characterizing Ischemic Stroke and Hemorrhagic Conversion in Infectious Endocarditis (P6.297)
Conclusions:The incidence of acute ischemic stroke in our population was 70.6%, with a third being silent infarcts. Hemorrhagic conversion occurred in 30% and was associated with cerebral microhemorrhages.Disclosure: Dr. Marquardt has nothing to disclose. Dr. Cho has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. Uchino has nothing to disclose. Dr. Wisco has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Marquardt, R., Cho, S.-M., Zhang, L., Uchino, K., Wisco, D. Tags: Cardiovascular Issues in Ischemic Stroke Source Type: research

Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK
Conclusion: HZ is an independent risk factor for vascular disease in the UK population, particularly for stroke, TIA, and MI in subjects affected before the age of 40 years. In older subjects, better ascertainment of vascular risk factors and earlier intervention may explain the reduction in risk of stroke after the occurrence of HZ.
Source: Neurology - January 20, 2014 Category: Neurology Authors: Breuer, J., Pacou, M., Gauthier, A., Brown, M. M. Tags: Stroke in young adults, Viral infections, All Cerebrovascular disease/Stroke, Cohort studies, Risk factors in epidemiology ARTICLE Source Type: research

Impact of Stroke Location on Stroke Outcome (P7.147)
CONCLUSIONS:Selective involvement of cortex or subcortical areas of brain due to ischemic stroke did not correlate with functional outcome at 3 months following thrombolysis. Patients with diabetes mellitus were more likely to have cortical strokes than subcortical strokes.Study Supported by:NoneDisclosure: Dr. Hinduja has nothing to disclose. Dr. Limaye has nothing to disclose. Dr. Patel has nothing to disclose. Dr. Mahuwala has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hinduja, A., Limaye, K., Patel, A., Mahuwala, Z. Tags: Cerebrovascular Disease and Interventional Neurology: Predictors of Outcome After Ischemic Stroke Source Type: research

Drivers of Costs Associated With Reperfusion Therapy in Acute Stroke: The Interventional Management of Stroke III Trial Clinical Sciences
Conclusions— Minimizing the time to start of intravenous tPA and decreasing the use of routine general anesthesia may improve the cost-effectiveness of medical and endovascular therapy for acute stroke. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00359424.
Source: Stroke - May 27, 2014 Category: Neurology Authors: Simpson, K. N., Simpson, A. N., Mauldin, P. D., Hill, M. D., Yeatts, S. D., Spilker, J. A., Foster, L. D., Khatri, P., Martin, R., Jauch, E. C., Kleindorfer, D., Palesch, Y. Y., Broderick, J. P., for the IMS III Investigators Tags: Thrombolysis Clinical Sciences Source Type: research

Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-Hour Exclusions and Association With Outcome: Data From Get With The Guidelines-Stroke Clinical Sciences
Conclusions— Patients with ECASS III–specific exclusion criteria for the >3 to 4.5 hours window are frequently treated with tPA. The presence of the additional exclusion criteria was not associated with worse outcomes in the >3 to 4.5 hours window compared with the 0 to 3 hours window.
Source: Stroke - August 25, 2014 Category: Neurology Authors: Cronin, C. A., Sheth, K. N., Zhao, X., Messe, S. R., Olson, D. M., Hernandez, A. F., Bhatt, D. L., Schwamm, L. H., Smith, E. E. Tags: Acute Cerebral Infarction, Thrombolysis Clinical Sciences Source Type: research

Effect of Blood Pressure Variability on Cardiovascular Outcome in Diabetic and Nondiabetic Patients with Stroke
Conclusions: We show that SBP variability is associated with cardiovascular outcomes in stroke patients without diabetes, but we didn’t find a correlation between SBP variability and cardiovascular outcomes in stroke patients with diabetes.
Source: Journal of Stroke and Cerebrovascular Diseases - September 1, 2014 Category: Neurology Authors: Bu-Xing Chen, Jun-Ping Tian, Hong-Xia Wang, Jie Xu, Feng-He Du, Xing-Quan Zhao Tags: Original Articles Source Type: research

Incidence, Trends, and Predictors of Ischemic Stroke 1 Year After an Acute Myocardial Infarction Clinical Sciences
Conclusions— The risk of ischemic stroke within a year after myocardial infarction is substantial but has clearly been reduced during the studied time period. The major predictive factors found to correlate well with previous investigations. Reperfusion treatment, thrombocyte aggregation inhibition, and lipid lowering are the main contributors to the observed risk reduction.
Source: Stroke - October 27, 2014 Category: Neurology Authors: Ulvenstam, A., Kajermo, U., Modica, A., Jernberg, T., Soderstrom, L., Mooe, T. Tags: Platelet function inhibitors, Acute myocardial infarction, Acute Cerebral Infarction, Platelets Clinical Sciences Source Type: research

Web-based tool for dynamic functional outcome after acute ischemic stroke and comparison with existing models
Background: Acute ischemic stroke (AIS) is one of the leading causes of death and adult disability worldwide. In the present study, we aimed to develop a web-based risk model for predicting dynamic functional status at discharge, 3-month, 6-month, and 1-year after acute ischemic stroke (Dynamic Functional Status after Acute Ischemic Stroke, DFS-AIS). Methods: The DFS-AIS was developed based on the China National Stroke Registry (CNSR), in which eligible patients were randomly divided into derivation (60%) and validation (40%) cohorts. Good functional outcome was defined as modified Rankin Scale (mRS) score???2 at discharge...
Source: BMC Neurology - November 25, 2014 Category: Neurology Authors: Ruijun JiWanliang DuHaipeng ShenYuesong PanPenglian WangGaifen LiuYilong WangHao LiXingquan ZhaoYongjun WangOn behalf of China National Stroke Registry (CNSR) investigators Source Type: research

Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke
Conclusions: GA could be a potential biomarker to predict the effects of dual and single antiplatelet therapy in patients with minor stroke or TIA.
Source: Neurology - March 30, 2015 Category: Neurology Authors: Li, J., Wang, Y., Wang, D., Lin, J., Wang, A., Zhao, X., Liu, L., Wang, C., Wang, Y., On behalf of the CHANCE Investigators Tags: Other cerebrovascular disease/ Stroke, Prognosis, All Cerebrovascular disease/Stroke, Infarction ARTICLE Source Type: research

Risk of ischemic stroke during periods of warfarin discontinuation for surgical procedures: A longitudinal study of 4060 patients with atrial fibrillation (P1.058)
CONCLUSIONS: The risk associated with discontinuation of warfarin for procedures must be recognized and considered in the risk benefit analysis of any procedure.Disclosure: Dr. Jahangir has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Suri has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Jahangir, N., Malik, A., Suri, M., Qureshi, A. Tags: Cerebrovascular Disease and Interventional Neurology: Atrial Fibrillation and Cardio-embolic Stroke Source Type: research

Mechanisms and Outcomes of Ischemic Stroke in Pregnancy and Postpartum: A Retrospective Cross-Sectional Study (P3.070)
CONCLUSIONS: Women with pregnancy-associated ischemic strokes were younger and had fewer vascular risk factors when compared with other young women with ischemic strokes. Outcomes were similar in the two groups, with a substantial proportion of poor outcomes in both groups. Our results are limited by the small sample size and retrospective nature of the study. Larger studies are needed to better characterize the pathophysiology of pregnancy-associated stroke.Disclosure: Dr. Miller has nothing to disclose. Dr. Yaghi has nothing to disclose. Dr. Boehme has nothing to disclose. Dr. Willey has nothing to disclose. Dr. Elkind h...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Miller, E., Yaghi, S., Boehme, A., Willey, J., Elkind, M., Marshall, R. Tags: Cerebrovascular Disease and Interventional Neurology: Ischemic Stroke Outcome Source Type: research

Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality Clinical Sciences
Conclusions— Our findings suggest that elevated tHcy levels in the acute phase of an ischemic stroke can predict mortality, especially in stroke patients with the large-vessel atherosclerosis subtype.
Source: Stroke - August 24, 2015 Category: Neurology Authors: Shi, Z., Guan, Y., Huo, Y. R., Liu, S., Zhang, M., Lu, H., Yue, W., Wang, J., Ji, Y. Tags: Acute Cerebral Infarction Clinical Sciences Source Type: research

Glycemic Variability and Functional Outcome After Acute Ischemic Stroke (P1.191)
Conclusions: An elevated GV on day 1 was significantly associated with worse functional outcome in patients with ischemic stroke. GV could be an important therapeutic target in the early management of acute ischemic stroke.Disclosure: Dr. Camara-Lemarroy has nothing to disclose. Dr. González-Moreno has nothing to disclose. Dr. Garza-Villarreal has nothing to disclose. Dr. Treviño-Herrera has nothing to disclose. Dr. Tena-Montiel has nothing to disclose. Dr. Muruet has nothing to disclose. Dr. Gongora Rivera has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Camara-Lemarroy, C., Gonzalez-Moreno, E., Garza-Villarreal, E., Trevino-Herrera, A., Tena-Montiel, R., Muruet, W., Gongora Rivera, J. Tags: Ischemic Stroke Outcomes Source Type: research

Factors associated with delay in presentation to the hospital for young adults with ischemic stroke (P3.237)
Conclusions: A majority of young adults with ischemic stroke presented outside the time window for intravenous fibrinolysis. Diabetes, single status, and unemployed status were associated with delayed presentation. Disclosure: Dr. Leung has nothing to disclose. Dr. Louis R. Caplan has received personal compensation in an editorial capacity for JAMA Neurology.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Leung, L., Caplan, L. Tags: Stroke in the Young Source Type: research